Associate Director, Analytical Development – Small Molecule

About this role

Centessa Pharmaceuticals, a wholly subsidiary of Eli Lilly and Company is advancing a portfolio of high conviction programs with strong biological validation. Our asset-centric model offers a unique R&D logic that has been applied by single asset companies to improve productivity. This operating model has minimal centralized infrastructure, reduced hierarchy, and exclusive focus on data driven capital allocation. Our teams are uniquely incentivized to expeditiously interrogate key scientific hypotheses. We believe the asset-centric model can lead to improved success rates for programs with greater speed and modest costs.

Description of Role

Centessa continues to expand its CMC group and currently seeks an Associate Director of Analytical R&D within the CMC group. The successful candidate will have hands-on experience leading the execution of small molecule analytical activities across early to late-stage development. This position will oversee work with various vendors and oversee analytical functions across programs. Comprehensive working knowledge of cGMP and regulatory guidance as they relate to development, testing, characterization, and shelf-life management of biologics is paramount. This position will be accountable for design, execution, and reporting of analytical data at external CDMOs to meet company deliverables and timelines. Travel to vendors both domestically and internationally will be required.

Key Responsibilities